Phosphoenix raises EUR 1.3 million in financing round backed by ROM InWest

• Phosphoenix raised EUR 1.3 million in a private financing round that included a new investment from ROM InWest.
• Funding targets faster preparation for a first-in-human clinical study in 2027, alongside further development of its neurostimulation system.
• Phosphoenix develops a brain implant designed to create artificial vision for people with severe blindness by directly stimulating the LGN region.
• The company is also preparing a roughly EUR 20 million Series A round to finance its clinical development program.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ROM InWest BV published the original content used to generate this news brief on September 16, 2026, and is solely responsible for the information contained therein.